Xin Yuze, Sun Hongru, Peng Shuangjie, Yin Xuejun, Ge Anqi, Liu Xinyan, Wang Tengyi, Sun Jingxue, Wu Yanmeizhi, Law Kristy, Trieu Kathy, Wu Jason H Y, Qiao Hong, Tian Maoyi
School of Public Health, Harbin Medical University, Harbin, China.
School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
J Gen Intern Med. 2024 Dec 11. doi: 10.1007/s11606-024-09251-2.
'Food is Medicine', a rapidly growing innovative intervention, has been shown to improve the management of type 2 diabetes mellitus (T2DM). However, due to the unique characteristics of Chinese dietary culture, it remains unclear whether such intervention measures can be implemented in China.
To identify the potential barriers and facilitators to implementing 'Food is Medicine' intervention for the management of people living with T2DM in three Chinese provinces.
Face-to-face semi-structured individual in-depth interview and focus group discussions in Heilongjiang, Hubei and Ningxia provinces in China.
People living with T2DM.
Both inductive and deductive methods were used to analyse the interview data, guided by the COM-B framework.
A total of 97 individuals participated in the study. Participants were concerned about the prices of buying prescribed meals, if not fully subsidised by healthcare system. Other barriers included the potential challenge to adhering to prescribed meals for long periods if the variety was limited, the difficulties in delivering fresh food or meals to remote areas and the lack of knowledge of healthy diets among the people living with T2DM and their relatives. In contrast, clinicians' confidence in the effectiveness of food and meal prescription, the opportunities to collaborate with community canteens on producing prescribed foods, and the convenience of preparing food for people with T2DM were identified as the main enablers.
There are presently several potential barriers to future implementing 'Food is Medicine' to manage people living with T2DM. But there are also clear opportunities to develop a context-tailored 'Food is Medicine' intervention in China.
“食物即药物”是一种迅速发展的创新干预措施,已被证明可改善2型糖尿病(T2DM)的管理。然而,由于中国饮食文化的独特性,尚不清楚此类干预措施能否在中国实施。
确定在中国三个省份实施“食物即药物”干预措施以管理T2DM患者的潜在障碍和促进因素。
在中国黑龙江省、湖北省和宁夏回族自治区进行面对面的半结构化个人深度访谈和焦点小组讨论。
T2DM患者。
采用归纳法和演绎法,在COM-B框架的指导下分析访谈数据。
共有97人参与了该研究。参与者担心如果医疗系统没有全额补贴,购买规定餐食的价格会很高。其他障碍包括如果种类有限,长期坚持规定餐食可能面临的挑战、向偏远地区运送新鲜食品或餐食的困难以及T2DM患者及其亲属缺乏健康饮食知识。相比之下,临床医生对食物和餐食处方有效性的信心、与社区食堂合作生产规定食物的机会以及为T2DM患者准备食物的便利性被确定为主要促进因素。
目前,未来实施“食物即药物”来管理T2DM患者存在若干潜在障碍。但在中国也有明确的机会来开发适合具体情况的“食物即药物”干预措施。